New patent for Currax drug ONZETRA XSAIL
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Currax and is included in one NDA. […]
Patent Added
Patent Added
Patent Added
New patent for Pfizer drug IBRANCE
Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It
Patent Added
New patent for Gilead Sciences drug GENVOYA
Annual Drug Patent Expirations for GENVOYA Genvoya is a drug marketed by Gilead Sciences Inc and is included in one
Patent Added
New patent for Leo Pharma drug ENSTILAR
Annual Drug Patent Expirations for ENSTILAR Enstilar is a drug marketed by Leo Pharma As and is included in one
Patent Added
New patent for Ipsen Inc drug ONIVYDE
Annual Drug Patent Expirations for ONIVYDE Onivyde is a drug marketed by Ipsen Inc and is included in one NDA.
Patent Added
New patent for Persion drug ZOHYDRO ER
Annual Drug Patent Expirations for ZOHYDRO+ER Zohydro Er is a drug marketed by Persion and is included in one NDA.
Patent Added
New patent for Sebela Ireland drug NAFTIN
Annual Drug Patent Expirations for NAFTIN Naftin is a drug marketed by Sebela Ireland Ltd and is included in three
Patent Added
New patent for Antares Pharma drug OTREXUP
Annual Drug Patent Expirations for OTREXUP Otrexup is a drug marketed by Antares Pharma Inc and is included in one
Patent Added
New patent for Antares Pharma drug OTREXUP PFS
Annual Drug Patent Expirations for OTREXUP+PFS Otrexup Pfs is a drug marketed by Antares Pharma Inc and is included in
